Jacob C Steigmann, Xiaofeng Zhou, Lauren N Suttenberg, Irha Salman, Zainab F Rehmathullah, Jason B Weinberg
{"title":"免疫蛋白酶体抑制剂对小鼠肝炎病毒 1 株急性呼吸道感染的影响。","authors":"Jacob C Steigmann, Xiaofeng Zhou, Lauren N Suttenberg, Irha Salman, Zainab F Rehmathullah, Jason B Weinberg","doi":"10.1128/jvi.01238-24","DOIUrl":null,"url":null,"abstract":"<p><p>The immunoproteasome (IP) is a predominantly inducible component of the ubiquitin proteasome system that plays key roles in multiple aspects of immune function, inflammation, and protein homeostasis. We used murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, to define the role of IP activity during acute coronavirus respiratory infection. Expression of the β5i subunit of the IP and cytokines that induce IP activity, including IFN-γ, TNF-α, and IFN-β, increased in lungs and livers of CH3/HeJ mice following intranasal infection with MHV-1. IP inhibition using ONX-0914 did not affect MHV-1 replication in bone marrow-derived dendritic cells <i>in vitro</i>. IP inhibition <i>in vivo</i> exacerbated virus-induced weight loss and mortality but had no effect on virus replication in lungs or livers. IP inhibition had minimal effect on virus-induced pulmonary inflammation but led to substantially increased liver pathology, including greater upregulation of pro-inflammatory cytokines and histological evidence of inflammation and necrosis. Those findings were associated with evidence of increased endoplasmic reticulum stress although not with accumulation of ubiquitinated protein. Our results indicate that the IP is a protective host factor during acute MHV-1 infection.</p><p><strong>Importance: </strong>Inflammatory responses triggered by acute infection by respiratory viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drive morbidity and mortality. Infection of mice with murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, is a useful model to study the pathogenesis of coronavirus respiratory infections. The immunoproteasome is an inducible component of the ubiquitin proteasome system that is poised to contribute to multiple aspects of immune function, inflammation, and protein homeostasis during an infection. We used the MHV-1 model to define the role of the immunoproteasome in coronavirus pathogenesis. We found that immunoproteasome subunit expression increases in the lungs and the liver during acute MHV-1 respiratory infection. Inhibition of immunoproteasome activity did not affect MHV-1 replication but increased MHV-1-induced weight loss, mortality, and inflammation in lungs and livers. Thus, our findings indicate that the immunoproteasome is a critical protective host factor during coronavirus respiratory infection.</p>","PeriodicalId":17583,"journal":{"name":"Journal of Virology","volume":" ","pages":"e0123824"},"PeriodicalIF":4.0000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1.\",\"authors\":\"Jacob C Steigmann, Xiaofeng Zhou, Lauren N Suttenberg, Irha Salman, Zainab F Rehmathullah, Jason B Weinberg\",\"doi\":\"10.1128/jvi.01238-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The immunoproteasome (IP) is a predominantly inducible component of the ubiquitin proteasome system that plays key roles in multiple aspects of immune function, inflammation, and protein homeostasis. We used murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, to define the role of IP activity during acute coronavirus respiratory infection. Expression of the β5i subunit of the IP and cytokines that induce IP activity, including IFN-γ, TNF-α, and IFN-β, increased in lungs and livers of CH3/HeJ mice following intranasal infection with MHV-1. IP inhibition using ONX-0914 did not affect MHV-1 replication in bone marrow-derived dendritic cells <i>in vitro</i>. IP inhibition <i>in vivo</i> exacerbated virus-induced weight loss and mortality but had no effect on virus replication in lungs or livers. IP inhibition had minimal effect on virus-induced pulmonary inflammation but led to substantially increased liver pathology, including greater upregulation of pro-inflammatory cytokines and histological evidence of inflammation and necrosis. Those findings were associated with evidence of increased endoplasmic reticulum stress although not with accumulation of ubiquitinated protein. Our results indicate that the IP is a protective host factor during acute MHV-1 infection.</p><p><strong>Importance: </strong>Inflammatory responses triggered by acute infection by respiratory viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drive morbidity and mortality. Infection of mice with murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, is a useful model to study the pathogenesis of coronavirus respiratory infections. The immunoproteasome is an inducible component of the ubiquitin proteasome system that is poised to contribute to multiple aspects of immune function, inflammation, and protein homeostasis during an infection. We used the MHV-1 model to define the role of the immunoproteasome in coronavirus pathogenesis. We found that immunoproteasome subunit expression increases in the lungs and the liver during acute MHV-1 respiratory infection. Inhibition of immunoproteasome activity did not affect MHV-1 replication but increased MHV-1-induced weight loss, mortality, and inflammation in lungs and livers. Thus, our findings indicate that the immunoproteasome is a critical protective host factor during coronavirus respiratory infection.</p>\",\"PeriodicalId\":17583,\"journal\":{\"name\":\"Journal of Virology\",\"volume\":\" \",\"pages\":\"e0123824\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Virology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1128/jvi.01238-24\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/jvi.01238-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
免疫蛋白酶体(IP)是泛素蛋白酶体系统的主要诱导成分,在免疫功能、炎症和蛋白质稳态等多个方面发挥着关键作用。我们利用小鼠肝炎病毒 1 株(MHV-1)(一种小鼠冠状病毒)来确定 IP 在冠状病毒急性呼吸道感染期间的作用。鼻内感染 MHV-1 后,CH3/HeJ 小鼠肺部和肝脏中 IP 的 β5i 亚基和诱导 IP 活性的细胞因子(包括 IFN-γ、TNF-α 和 IFN-β)的表达量增加。使用 ONX-0914 抑制 IP 不会影响骨髓树突状细胞中 MHV-1 的体外复制。体内的 IP 抑制会加剧病毒引起的体重下降和死亡率,但对肺部或肝脏中的病毒复制没有影响。IP 抑制对病毒诱导的肺部炎症影响极小,但会导致肝脏病理变化显著增加,包括促炎细胞因子的更高上调以及炎症和坏死的组织学证据。这些发现与内质网应激增加的证据有关,但与泛素化蛋白质的积累无关。我们的研究结果表明,在 MHV-1 急性感染期间,IP 是一种保护性宿主因子:重要意义:呼吸道病毒(如严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2))急性感染引发的炎症反应会导致发病和死亡。用小鼠冠状病毒 1 型肝炎病毒(MHV-1)感染小鼠是研究冠状病毒呼吸道感染发病机制的有用模型。免疫蛋白酶体是泛素蛋白酶体系统的一个可诱导成分,在感染期间可对免疫功能、炎症和蛋白质稳态等多个方面做出贡献。我们利用 MHV-1 模型来确定免疫蛋白酶体在冠状病毒发病机制中的作用。我们发现,在急性 MHV-1 呼吸道感染期间,免疫蛋白酶体亚基在肺部和肝脏中的表达增加。抑制免疫蛋白酶体的活性不会影响 MHV-1 的复制,但会增加 MHV-1 引起的体重下降、死亡率以及肺和肝脏的炎症。因此,我们的研究结果表明,在冠状病毒呼吸道感染期间,免疫蛋白酶体是一种关键的宿主保护因子。
Effects of immunoproteasome inhibition on acute respiratory infection with murine hepatitis virus strain 1.
The immunoproteasome (IP) is a predominantly inducible component of the ubiquitin proteasome system that plays key roles in multiple aspects of immune function, inflammation, and protein homeostasis. We used murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, to define the role of IP activity during acute coronavirus respiratory infection. Expression of the β5i subunit of the IP and cytokines that induce IP activity, including IFN-γ, TNF-α, and IFN-β, increased in lungs and livers of CH3/HeJ mice following intranasal infection with MHV-1. IP inhibition using ONX-0914 did not affect MHV-1 replication in bone marrow-derived dendritic cells in vitro. IP inhibition in vivo exacerbated virus-induced weight loss and mortality but had no effect on virus replication in lungs or livers. IP inhibition had minimal effect on virus-induced pulmonary inflammation but led to substantially increased liver pathology, including greater upregulation of pro-inflammatory cytokines and histological evidence of inflammation and necrosis. Those findings were associated with evidence of increased endoplasmic reticulum stress although not with accumulation of ubiquitinated protein. Our results indicate that the IP is a protective host factor during acute MHV-1 infection.
Importance: Inflammatory responses triggered by acute infection by respiratory viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drive morbidity and mortality. Infection of mice with murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, is a useful model to study the pathogenesis of coronavirus respiratory infections. The immunoproteasome is an inducible component of the ubiquitin proteasome system that is poised to contribute to multiple aspects of immune function, inflammation, and protein homeostasis during an infection. We used the MHV-1 model to define the role of the immunoproteasome in coronavirus pathogenesis. We found that immunoproteasome subunit expression increases in the lungs and the liver during acute MHV-1 respiratory infection. Inhibition of immunoproteasome activity did not affect MHV-1 replication but increased MHV-1-induced weight loss, mortality, and inflammation in lungs and livers. Thus, our findings indicate that the immunoproteasome is a critical protective host factor during coronavirus respiratory infection.
期刊介绍:
Journal of Virology (JVI) explores the nature of the viruses of animals, archaea, bacteria, fungi, plants, and protozoa. We welcome papers on virion structure and assembly, viral genome replication and regulation of gene expression, genetic diversity and evolution, virus-cell interactions, cellular responses to infection, transformation and oncogenesis, gene delivery, viral pathogenesis and immunity, and vaccines and antiviral agents.